A randomized controlled trial of an information prescription for pediatric patient education on the Internet

Donna M D'Alessandro1, Clarence D Kreiter, Susan L Kinzer

  • 1Department of Pediatrics, University of Iowa Roy J. and Lucille A. Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242-1009, USA. donna-dalessandro@uiowa.edu

Insights

Pediatrician-provided Information Prescriptions (IPs) encourage parents to use the internet for health information. This study found IPs increased parents' use of reliable online health resources and positively changed their attitudes toward using them.

Area of Science:

  • Pediatric Health
  • Health Informatics
  • Patient Education

Background:

  • Parents frequently use the internet for health information concerning their children.
  • Information Prescriptions (IPs) are evidence-based resources to manage health concerns.
  • There is a need to guide parents toward reliable online health information.

Purpose of the Study:

  • To evaluate if pediatrician-provided Information Prescriptions (IPs) influence parental attitudes and behaviors regarding internet health information use.
  • To assess the impact of a pediatrician-provided IP on parental engagement with online health resources.

Main Methods:

  • A randomized controlled trial was conducted with parents attending a pediatric clinic.
  • Participants completed pre-intervention and follow-up surveys.
  • The intervention group received an IP and computer training; the control group did not.

Main Results:

  • Parents in the intervention group showed increased internet use for general and child health information compared to controls.
  • A significant portion of internet resources used by the intervention group were prescribed via the IP.
  • Parents who utilized the IP reported higher satisfaction and likelihood of future use and recommendation.

Conclusions:

  • Information Prescriptions (IPs) are effective in enhancing parental utilization of credible online health information.
  • Pediatrician-led provision of IPs can lead to positive shifts in parental health information-seeking behaviors.
  • Implementing IPs in pediatric practices is a feasible strategy to improve patient education and resource navigation.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...